Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$533,225
+$86,719 QoQ
Shares Held
2,119
+3.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#3,103
of 4,153 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hoxton Planning & Management, LLC holds $4,792,204 across 8 Drug Manufacturers - General names. ABBV ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,255 | $1,505,284 | |
| 2 | JNJ |
Johnson & Johnson
|
2,875 | $730,163 | |
| 3 | PFE |
Pfizer Inc
|
26,907 | $647,920 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,119 | $533,225 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,039 | $383,947 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,925 | $375,862 | |
| 7 | AMGN |
Amgen Inc
|
913 | $330,615 | |
| 8 | AZN |
Astrazeneca PLC
|
1,504 | $285,188 |
All Filings in ABBV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $533,225 | 2,119 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $446,506 | 2,053 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $483,256 | 2,115 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $476,509 | 2,058 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $377,922 | 2,036 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $446,068 | 2,129 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $364,818 | 2,053 | Shares | Sole | 2025-09-08 | |
| 2024-09-30 | $361,388 | 1,830 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $255,907 | 1,492 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $279,887 | 1,537 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $213,083 | 1,375 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $221,652 | 1,487 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $222,978 | 1,655 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $221,205 | 1,388 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $227,546 | 1,408 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||